Discovery of Novel ADC Payloads to Combat Topo1 & Tubulin Inhibitor Resistant Tumors
Time: 9:45 am
day: Conference Day Two
Details:
- Assessing preclinical data for protein translation inhibitor payload demonstrating efficacy in tumors resistant to Topo1 and tubulin ADCs
- Learning about a discovery platform for natural product payloads with novel modes of action
- Discussing potential of other pipeline natural products for ADCs
